Stockreport

HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference

HilleVax, Inc.  (HLVX) 
PDF BOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vac [Read more]